Company intelligence / Profile preview

Mindright

California, United States

Ownership: Private
Development stage: Other

Overview

Mindright’s commercial supplements and nootropic snacks are formulated to support focus, clarity, and mood, using natural ingredients like mushrooms, ashwagandha, and adaptogens. No clinical trial data provided; positioned as wellness/nutraceutical rather than regulated drug

Therapeutic areas: OtherNeurologyPsychiatry
Modalities: Nootropic supplementFunctional foodMushroom-based nutraceutical
Industry: Food & Nutrition

Partnerships

Celebrity investorsDyrdek Machine

Beyond the preview

Go deeper on Mindright.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mindright.

Explore the full profile